[1]
“UROKINASE PLASMINOGEN ACTIVATOR (uPA) AND PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN BREAST CANCER – CORRELATION WITH TRADITIONAL PROGNOSTIC FACTORS”, Radiol Oncol, vol. 49, no. 4, Jan. 2016, Accessed: Sep. 24, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/2212